[PDF][PDF] Benign breast diseases: classification, diagnosis, and management
M Guray, AA Sahin - The oncologist, 2006 - Wiley Online Library
Learning Objectives After completing this course, the reader will be able to: 1.Discuss the
clinical and histopathologic features of benign conditions of the breast. 2.Identify the risks of …
clinical and histopathologic features of benign conditions of the breast. 2.Identify the risks of …
The 2019 WHO classification of tumours of the breast
The newly published World Health Organization (WHO) Classification of Tumours of the
breast features significant changes compared to earlier editions. In this review, we outline the …
breast features significant changes compared to earlier editions. In this review, we outline the …
A review of entropy generation in nanofluid flow
The development and use of nanofluids, ie, dilute suspensions of nanoparticles in liquids,
have found a wide range of applications in consumer products, nanomedicine, energy …
have found a wide range of applications in consumer products, nanomedicine, energy …
[HTML][HTML] PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
The ErbB2-targeting antibody, trastuzumab (Herceptin), has remarkable therapeutic efficacy
in certain patients with ErbB2-overexpressing tumors. The overall trastuzumab response rate…
in certain patients with ErbB2-overexpressing tumors. The overall trastuzumab response rate…
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Phosphatidylinositol 3-kinase (PI3K)/AKT pathway aberrations are common in cancer. By
applying mass spectroscopy–based sequencing and reverse-phase protein arrays to 547 …
applying mass spectroscopy–based sequencing and reverse-phase protein arrays to 547 …
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
The development of life-threatening cancer metastases at distant organs requires
disseminated tumour cells’ adaptation to, and co-evolution with, the drastically different …
disseminated tumour cells’ adaptation to, and co-evolution with, the drastically different …
The effects of brand experiences, trust and satisfaction on building brand loyalty; an empirical research on global brands
Marketing academics and practitioners have acknowledged that consumers look for brands
that provide them with unique and memorable experiences. As a result, the concept of brand …
that provide them with unique and memorable experiences. As a result, the concept of brand …
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
The centrosomes are thought to maintain genomic stability through the establishment of
bipolar spindles during cell division, ensuring equal segregation of replicated chromosomes to …
bipolar spindles during cell division, ensuring equal segregation of replicated chromosomes to …
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal …
…, MC Green, SE Singletary, KK Hunt, AA Sahin… - Clinical Cancer …, 2007 - AACR
Purpose: Findings from our previously published phase III randomized trial showed a high
pathologic complete remission (CR) rate in patients with human epidermal growth factor …
pathologic complete remission (CR) rate in patients with human epidermal growth factor …
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
The RAS–ERK pathway is known to play a pivotal role in differentiation, proliferation and
tumour progression. Here, we show that Erk downregulates Forkhead box O 3a (FOXO3a) by …
tumour progression. Here, we show that Erk downregulates Forkhead box O 3a (FOXO3a) by …